[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368110-105":59,"doc-detail-368110-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-clinical-relevance-of-fto-as-a-demethylase-beyond-cancer-molecular-mechanisms-and-therapeutic-opportunities","The Clinical Relevance of FTO as a Demethylase Beyond Cancer - Molecular Mechanisms and Therapeutic Opportunities","","The fat mass and obesity-associated (FTO) gene is a central regulator linked to obesity and metabolic control, with FTO single nucleotide polymorphisms influencing multisystem disease pathophysiology through epigenetic mechanisms. Although FTO has been extensively reviewed in cancer, its contribution to non-malignant conditions is insufficiently synthesized. This review systematically evaluates FTO molecular functions across non-oncologic diseases and examines demethylation mechanisms, biological activities, and therapeutic opportunities, including computational docking and bibliometric mapping of research trends.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-clinical-relevance-of-fto-as-a-demethylase-beyond-cancer-molecular-mechanisms-and-therapeutic-opportunities/368110/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-clinical-relevance-of-fto-as-a-demethylase-beyond-cancer-molecular-mechanisms-and-therapeutic-opportunities/368110.png","ImageObject",300,407,{"name":92,"@type":93},"moss~","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of the review on FTO?","Question",{"text":112,"@type":113},"The review systematically assesses FTO’s molecular functions in diseases other than cancer, emphasizing its demethylase activity and related biological roles.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does FTO regulate gene expression in the context discussed?",{"text":117,"@type":113},"FTO regulates gene expression by modulating RNA methylation, particularly through demethylation of N6-methyladenosine (m6A), affecting RNA splicing, stability, and translation.",{"name":119,"@type":110,"acceptedAnswer":120},"What methods are used to evaluate therapeutic and research trends?",{"text":121,"@type":113},"The review uses AutoDockTools 1.5.7 to simulate FTO–drug binding interactions and VOSviewer for bibliometric analysis to visualize term frequency, co-occurrence, and research hotspots.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368110,1790794556,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},962090895452,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Volume 17, Number 5; 2428-2447, October 2026  \n[http://dx.doi.org/10.14336/AD.2025.0916](http://dx.doi.org/10.14336/AD.2025.0916)  \nReview  \nThe Clinical Relevance ofFTO as a Demethylase Beyond Cancer: Molecular Mechanisms and Therapeutic  \nOpportunities  \nCun-yang Guo1,2\\#, Yi-fei Du1,2\\#, Hui-cong Yan2,3, Xin-ming Fan4, Fang-qi Tian2, Ping Xu2*  \n1School of Public Health, Binzhou Medical University, Yantai, Shandong, 264003, China. 2Laboratory of Radiation-induced Diseases and Molecule-targeted Drugs, School of Food and Biomedicine, Zaozhuang University, Zaozhuang, Shandong, 277160, China. 3School of Public Health, Shandong Second Medical University, Weifang, Shandong, 261000, China. 4Department of Radiotherapy, Zaozhuang Municipal Hospital, Zaozhuang, Shandong, 277100, China  \n[Received July 23, 2025; Revised September 9, 2025; Accepted September 10, 2025]  \nABSTRACT: The fat mass and obesity-associated (FTO) gene is a key gene that has been linked to obesity and metabolic regulation. FTO single nucleotide polymorphisms (SNPs) significantly contribute to the pathophysiology of various multisystem diseases via epigenetic mechanisms. Although FTO has been extensively reviewed in the context of cancer, a comprehensive evaluation of its role in non-malignant diseases is currently lacking. This review aimed to systematically assess the molecular functions of FTO in the context of diseases other than cancer based on recent insights from the literature. Relevant studies were retrieved by systematically searching the PubMed database to explore the mechanisms through which FTO acts as a mediator of demethylation, its biological activities, and its functional roles in a spectrum of non-oncologic diseases. To explore pharmacological interactions, AutoDockTools 1.5.7 was used to simulate binding interactions between FTO and conventional therapeutic agents. Additionally, we conducted a bibliometric analysis using VOSviewer to visualize the frequency and co-occurrence ofFTO-related terms, thereby helping to map research trends and knowledge gaps in the field. FTO regulates gene expression by modulating RNA methylation, particularly through the demethylation of N6-methyladenosine (m6A), thereby influencing RNA splicing, stability, and translation. This regulatory activity plays a major role in processes such as inflammation and fibrosis. Dysregulation of FTO has been implicated in several non-malignant diseases, including metabolic disorders, neurological diseases, and cardiovascular conditions. Computational docking studies showed that FTO exhibited strong binding affinity with two drugs and moderate affinity with eight others. Bibliometric analysis revealed high-frequency keywords and visualized research hotspots pertaining to FTO, providing valuable insight into current areas of scientific interest and potential future directions of study. FTO functions as a key epigenetic regulator in non-cancerous diseases and represents a promising biomarker and therapeutic target. Our findings underscore the importance of FTO–drug interactions and suggest that small-molecule FTO modulators may hold therapeutic value for managing a variety of non-oncologic conditions.  \nKeywords: FTO, RNA demethylation, epigenetics, molecular docking, bibliometric analysis  \n1. Introduction associated protein (FTO) have been increasingly established as a key regulator of diverse physiological and  \nSince its identification as a body mass index (BMI) - pathological processes [2-4] . While many studies have associated gene in 2007 [1], the fat mass and obesity- probed the molecular roles of FTO in oncogenesis, its  \n\n| functions beyond cancer remain incompletely understood, particularly in the context of metabolic dysregulation, neurological degeneration, apoptosis, and cardiovascular repair. This review provides an overview of recent findings detailing the ability of FTO to orchestrate pathological networks in non-neoplastic disorders, with a particular focus on how ","cbCairWjA1eCix5t","https://ap.wps.com/l/cbCairWjA1eCix5t","pdf",1482834,"English","# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"What is the main focus of the review on FTO?\",\"answer\":\"The review systematically assesses FTO’s molecular functions in diseases other than cancer, emphasizing its demethylase activity and related biological roles.\"},{\"question\":\"How does FTO regulate gene expression in the context discussed?\",\"answer\":\"FTO regulates gene expression by modulating RNA methylation, particularly through demethylation of N6-methyladenosine (m6A), affecting RNA splicing, stability, and translation.\"},{\"question\":\"What methods are used to evaluate therapeutic and research trends?\",\"answer\":\"The review uses AutoDockTools 1.5.7 to simulate FTO–drug binding interactions and VOSviewer for bibliometric analysis to visualize term frequency, co-occurrence, and research hotspots.\"}]","The Clinical Relevance of FTO as a Demethylase Beyond Cancer - Molecular Mechanisms and Therapeutic Opportunities | PDF",1790175036,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a04e53a3b0bd884b00293c33a5659a4.webp",983,1272,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e40a822bf970404fb3fcbee8685bdfbc.webp",982,1270,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d5b730b3a7c665eeaa4e428217ec677a.webp",981,1269,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3cd98f4119c1a3eb1c6c27bbfbcefb1.webp",980,1268]